Clinical Trials Browser

OTHER × Lymphoma, Extranodal NK-T-Cell × 30 days × Clear all

NCT07457177 2026-03-09

Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

Phase 2 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell

NCT07382817 2026-02-27

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

Phase 1 Recruiting

Neoplasms, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell